{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:26:47Z","timestamp":1741325207346,"version":"3.38.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-024-03047-1","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T17:01:38Z","timestamp":1728147698000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of venous thromboembolism after discontinuing prophylactic or therapeutic anticoagulation in patients with haematologic malignancies because of thrombocytopenia"],"prefix":"10.1007","volume":"58","author":[{"given":"Tanja","family":"Wenning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kudlek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Nuri","family":"H\u00fcnerlit\u00fcrkoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,5]]},"reference":[{"key":"3047_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/17474086.2021.1924053","volume":"14","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari H, Soff GA (2021) Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia. Expert Rev Hematol 14:437\u2013448","journal-title":"Expert Rev Hematol"},{"key":"3047_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12885-019-5354-5","volume":"19","author":"D Weycker","year":"2019","unstructured":"Weycker D, Hatfield M, Grossman A, Hanau A, Lonshteyn A, Sharma A, Chandler D (2019) Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice. BMC Cancer 19:151","journal-title":"BMC Cancer"},{"key":"3047_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/ejh.13595","volume":"106","author":"JL Shaw","year":"2021","unstructured":"Shaw JL, Nielson CM, Park JK, Marongiu A, Soff GA (2021) The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies. Eur J Haematol 106:662\u2013672","journal-title":"Eur J Haematol"},{"key":"3047_CR4","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1515\/cclm-2019-0380","volume":"57","author":"PJ Vinholt","year":"2019","unstructured":"Vinholt PJ (2019) The role of platelets in bleeding in patients with thrombocytopenia and haematological disease. Clin Chem Lab Med 57:1808\u20131817","journal-title":"Clin Chem Lab Med"},{"key":"3047_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2020.12.016","volume":"199","author":"F Moik","year":"2021","unstructured":"Moik F, Makatsariya A, Ay C (2021) Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia\u2014a case-based review of clinical management. Thromb Res 199:38\u201342","journal-title":"Thromb Res"},{"key":"3047_CR6","first-page":"171","volume":"17","author":"M Napolitano","year":"2019","unstructured":"Napolitano M, Saccullo G, Marietta M, Carpenedo M, Castaman G, Cerchiara E, Chistolini A, Contino L, De Stefano V, Falanga A, Federici AB, Rossi E, Santoro R, Siragusa S, Gruppo Italiano Malattie EMatologiche dell\u2019Adulto (GIMEMA) (2019) Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus. Blood Transfus 17:171\u2013180","journal-title":"Blood Transfus"},{"key":"3047_CR7","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1080\/10428194.2017.1306644","volume":"58","author":"DE Houghton","year":"2017","unstructured":"Houghton DE, Key NS, Zakai NA, Laux JP, Shea TC, Moll S (2017) Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort. Leuk Lymphoma 58:2573\u20132581","journal-title":"Leuk Lymphoma"},{"key":"3047_CR8","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1182\/bloodadvances.2021005966","volume":"5","author":"BJ Carney","year":"2021","unstructured":"Carney BJ, Wang TF, Ren S, George G, Al Homssi A, Gaddh M, Connolly GC, Shah VI, Bogue T, Bartosic A, Neuberg D, Baumann Kreuziger L, Zwicker JI, VENUS Network Investigators (2021) Anticoagulation in cancer-associated thromboembolism with\u00a0thrombocytopenia: a prospective, multicenter cohort study. Blood Adv 5:5546\u20135553","journal-title":"Blood Adv"},{"key":"3047_CR9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/jth.14015","volume":"16","author":"BT Samuelson Bannow","year":"2018","unstructured":"Samuelson Bannow BT, Lee A, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M (2018) Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost 16:1246\u20131249","journal-title":"J Thromb Haemost"},{"key":"3047_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejim.2020.03.005","volume":"77","author":"A Leader","year":"2020","unstructured":"Leader A, Ten Cate V, Ten Cate-Hoek AJ, Beckers EAM, Spectre G, Giaccherini C, Gurevich-Shapiro A, Krashin E, Raanani P, Schouten HC, Falanga A, Hugo Ten Cate H (2020) Anticoagulation in thrombocytopenic patients with hematological malignancy: a multinational clinical vignette-based experiment. Eur J Intern Med 77:86\u201396","journal-title":"Eur J Intern Med"},{"key":"3047_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.blre.2018.06.002","volume":"33","author":"N Kekre","year":"2019","unstructured":"Kekre N, Connors JM (2019) Venous thromboembolism incidence in hematologic malignancies. Blood Rev 33:24\u201332","journal-title":"Blood Rev"},{"key":"3047_CR12","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/j.1538-7836.2005.01467.x","volume":"3","author":"V De Stefano","year":"2005","unstructured":"De Stefano V, Sora F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, Zini G, Pagano L, Sica S, Leone G (2005) The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 3:1985\u20131992","journal-title":"J Thromb Haemost"},{"key":"3047_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ajh.25494","volume":"94","author":"DE Angelini","year":"2019","unstructured":"Angelini DE, Radivoyevitch T, McCrae KR, Khorana AA (2019) Bleeding incidence and risk factors among cancer patients treated with anticoagulation. Am J Hematol 94:780\u2013785","journal-title":"Am J Hematol"},{"key":"3047_CR14","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1002\/ajh.24526","volume":"91","author":"N Khanal","year":"2016","unstructured":"Khanal N, Bociek RG, Chen B, Vose JM, James O Armitage JO, Bierman PJ, Maness LJ, Lunning MA, Gundabolu K, Bhatt VR (2016) Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia. Am J Hematol 91:E468\u2013E472","journal-title":"Am J Hematol"},{"key":"3047_CR15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s12032-013-0772-8","volume":"31","author":"M Joks","year":"2014","unstructured":"Joks M, Czy\u017c A, Pop\u0142awski D, Komarnicki M (2014) Incidence and risk factors for central venous catheter-related thrombosis in hematological patients. Med Oncol 31:772","journal-title":"Med Oncol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-03047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-024-03047-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-03047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:24:53Z","timestamp":1741307093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-024-03047-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,5]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["3047"],"URL":"https:\/\/doi.org\/10.1007\/s11239-024-03047-1","relation":{},"ISSN":["1573-742X"],"issn-type":[{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2024,10,5]]},"assertion":[{"value":"17 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare to have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Because medical forms were anonymised patients consent und ethic approval were not necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable as all data were anonymised.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/Informed consent"}},{"value":"All authors approved the version to be published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}